Rallybio Corp
RLYBNasdaqCIK 1739410HealthcareFiscal year ends Dec 31
Reports and events: 88 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2708:08 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001628280-26-067422 |
| 2026-10-2616:53 ET | 8-K | 8.01 Other events | 0001193125-26-432114 |
| 2026-09-0916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-386511 |
| 2026-08-0608:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053880 |
| 2026-06-0108:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-249790 |
| 2026-05-1316:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-034580 |
| 2026-05-0616:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001674324-26-000004 |
| 2026-05-0407:54 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-202601 |
| 2026-03-3116:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-022385 |
| 2026-03-1617:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-018261 |
| 2026-03-0316:34 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001999371-26-004957 |
| 2026-03-0209:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-084444 |
| 2026-02-2716:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001674324-26-000002 |
| 2026-01-2917:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001739410-26-000010 |
| 2026-01-0216:05 ET | DEF 14A | Proxy statementPeriod 2026-01-26 | 0001140361-26-000191 |
| 2025-11-0608:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001739410-25-000132 |
| 2025-11-0608:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-25-000131 |
| 2025-08-2916:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-25-192749 |
| 2025-08-0708:33 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001739410-25-000112 |
| 2025-08-0708:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-25-000108 |
| 2025-07-0808:08 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001739410-25-000100 |
| 2025-06-2716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001739410-25-000093 |
| 2025-05-1608:31 ET | 8-K | 5.07 Shareholder vote results | 0001739410-25-000089 |
| 2025-05-0808:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001739410-25-000061 |
| 2025-05-0808:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-25-000059 |
| 2025-04-0808:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001739410-25-000052 |
| 2025-04-0716:39 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001739410-25-000045 |
| 2025-03-1316:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001739410-25-000041 |
| 2025-03-1316:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001739410-25-000040 |
| 2025-03-1308:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-25-000029 |
| 2025-02-2516:41 ET | 8-K | 3.01 Delisting notice | 0001739410-25-000021 |
| 2024-11-0716:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001739410-24-000136 |
| 2024-11-0708:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-24-000132 |
| 2024-09-1708:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001739410-24-000121 |
| 2024-08-0808:09 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001739410-24-000115 |
| 2024-08-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-24-000114 |
| 2024-07-2316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001739410-24-000105 |
| 2024-05-2116:22 ET | 8-K | 5.07 Shareholder vote results | 0001739410-24-000098 |
| 2024-05-0916:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001739410-24-000057 |
| 2024-05-0908:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-24-000053 |
| 2024-04-1116:09 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001739410-24-000045 |
| 2024-04-1016:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001739410-24-000040 |
| 2024-03-1216:26 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001739410-24-000035 |
| 2024-03-1208:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-24-000030 |
| 2024-02-1221:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-032553 |
| 2024-02-0608:15 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001739410-24-000012 |
| 2023-12-2008:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001739410-23-000019 |
| 2023-11-0916:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001739410-23-000014 |
| 2023-11-0908:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001739410-23-000011 |
| 2023-08-0816:18 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001739410-23-000007 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.